Ernexa Therapeutics (ERNAW) Current Deferred Tax Assets (2018 - 2020)

Ernexa Therapeutics has reported Current Deferred Tax Assets for 3 years, with the latest figure at $72000.0 in Q4 2020.

• For the quarter ending Q4 2020, Current Deferred Tax Assets fell 73.72% year-over-year to $72000.0; the trailing twelve-month figure through Dec 2020 stood at $72000.0 (down 73.72% YoY), and the FY2020 full-year result was $72000.0, down 73.72% from the prior year.
• Current Deferred Tax Assets for Q4 2020 stood at $72000.0, down from $274000.0 in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $424000.0 in Q4 2018, with the low at $72000.0 in Q4 2020.
• Historically, Current Deferred Tax Assets has averaged $256666.7 across 3 years, with a median of $274000.0 in 2019.
• Annual changes were most pronounced in 2019 — Current Deferred Tax Assets slumped 35.38% — and 2020, when it tumbled 73.72%.
• Ernexa Therapeutics' Current Deferred Tax Assets stood at $424000.0 in 2018, then tumbled by 35.38% to $274000.0 in 2019, then plunged by 73.72% to $72000.0 in 2020.
• The last three Current Deferred Tax Assets figures came in at $72000.0 (Q4 2020), $274000.0 (Q4 2019), and $424000.0 (Q4 2018), per Business Quant data.